Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Phibro Animal Health sees FY21 adjusted EPS $1.25-$1.27, consensus $1.21 » 16:44
05/06/21
05/06
16:44
05/06/21
16:44
PAHC

Phibro Animal Health

$25.81 /

+0.43 (+1.69%)

Sees FY21 revenue…

Sees FY21 revenue $826.1M-$830.1M, consensus $805.88M.

ShowHide Related Items >><<
PAHC Phibro Animal Health
$25.81 /

+0.43 (+1.69%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
PAHC Phibro Animal Health
$25.81 /

+0.43 (+1.69%)

Earnings
Phibro Animal Health sees Q4 adjusted EPS 30c-32c, consensus 28c » 16:44
05/06/21
05/06
16:44
05/06/21
16:44
PAHC

Phibro Animal Health

$25.81 /

+0.43 (+1.69%)

Sees Q4 revenue…

Sees Q4 revenue $213M-$217M, consensus $200.14M.

ShowHide Related Items >><<
PAHC Phibro Animal Health
$25.81 /

+0.43 (+1.69%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
PAHC Phibro Animal Health
$25.81 /

+0.43 (+1.69%)

Earnings
Phibro Animal Health reports Q3 adjusted EPS 30c, consensus 34c » 16:43
05/06/21
05/06
16:43
05/06/21
16:43
PAHC

Phibro Animal Health

$25.81 /

+0.43 (+1.69%)

Reports Q3 revenue $212M,…

Reports Q3 revenue $212M, consensus $208.05M. "The third quarter was another quarter of solid financial performance. Consolidated sales and adjusted diluted EPS were both ahead of guidance. Sales were comparable to the same quarter last year, while profitability declined slightly due to unfavorable product mix and increases in certain expenses, including incremental strategic investments in our future" said Jack Bendheim, Phibro's Chairman, President and Chief Executive Officer. Jack continued, "I am pleased to report that we received EU GMP approval for our new vaccine facility in Sligo, Ireland and we continue to build our companion animal pipeline, having recently finalized an agreement that adds two early-stage oral care projects. We expect a strong fourth quarter to close out our fiscal year."

ShowHide Related Items >><<
PAHC Phibro Animal Health
$25.81 /

+0.43 (+1.69%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
PAHC Phibro Animal Health
$25.81 /

+0.43 (+1.69%)

Over a quarter ago
Conference/Events
BofA to hold a virtual summit » 10:23
02/25/21
02/25
10:23
02/25/21
10:23
HSKA

Heska

$207.78 /

-0.35 (-0.17%)

, ZTS

Zoetis

$158.94 /

-0.1 (-0.06%)

, KIN

Kindred Biosciences

$4.74 /

+0.03 (+0.64%)

, IDXX

Idexx Laboratories

$529.59 /

-3.96 (-0.74%)

, PAHC

Phibro Animal Health

$21.80 /

-0.04 (-0.18%)

, ELAN

Elanco

$32.14 /

+0.57 (+1.81%)

Animal Health Virtual…

Animal Health Virtual Summit 2021 to be held on February 25.

ShowHide Related Items >><<
ZTS Zoetis
$158.94 /

-0.1 (-0.06%)

PAHC Phibro Animal Health
$21.80 /

-0.04 (-0.18%)

KIN Kindred Biosciences
$4.74 /

+0.03 (+0.64%)

IDXX Idexx Laboratories
$529.59 /

-3.96 (-0.74%)

HSKA Heska
$207.78 /

-0.35 (-0.17%)

ELAN Elanco
$32.14 /

+0.57 (+1.81%)

HSKA Heska
$207.78 /

-0.35 (-0.17%)

02/24/21 Alliance Global Partners
Heska price target raised to $230 from $167.50 at Alliance Global Partners
02/23/21 Piper Sandler
Heska price target raised to $220 from $157 at Piper Sandler
01/29/21 JPMorgan
Heska initiated with an Overweight at JPMorgan
11/23/20 Piper Sandler
Heska price target raised to $157 from $150 at Piper Sandler
ZTS Zoetis
$158.94 /

-0.1 (-0.06%)

02/17/21 Credit Suisse
Zoetis price target raised to $203 from $197 at Credit Suisse
11/12/20 Truist
Zoetis price target raised to $170 from $160 at Truist
11/06/20 Barclays
Zoetis price target raised to $189 from $175 at Barclays
09/21/20 Atlantic Equities
Zoetis initiated with an Overweight at Atlantic Equities
KIN Kindred Biosciences
$4.74 /

+0.03 (+0.64%)

12/24/20 Barclays
Kindred atopic dermatitis portfolio could net $130M in sales, says Barclays
12/18/20 Alliance Global Partners
Kindred Biosciences price target lowered to $9.25 from $10.25 at Alliance Global Partners
12/14/20 Lake Street
Kindred Biosciences struck 'terrific arrangement' with Elanco, says Lake Street
12/01/20 Alliance Global Partners
Kindred price target lowered to $10.25 from $12.50 at Alliance Global
IDXX Idexx Laboratories
$529.59 /

-3.96 (-0.74%)

02/17/21 Barclays
Idexx Laboratories initiated with an Overweight at Barclays
01/29/21 JPMorgan
Idexx Laboratories initiated with an Overweight at JPMorgan
08/17/20 Credit Suisse
Idexx Laboratories price target raised to $422 from $415 at Credit Suisse
08/04/20 Credit Suisse
Idexx Laboratories price target raised to $415 from $300 at Credit Suisse
PAHC Phibro Animal Health
$21.80 /

-0.04 (-0.18%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
ELAN Elanco
$32.14 /

+0.57 (+1.81%)

12/09/20 Argus
Elanco cut to Hold at Argus on margin pressure from Bayer unit deal
12/09/20 Argus
Elanco downgraded to Hold from Buy at Argus
ZTS Zoetis
$158.94 /

-0.1 (-0.06%)

PAHC Phibro Animal Health
$21.80 /

-0.04 (-0.18%)

KIN Kindred Biosciences
$4.74 /

+0.03 (+0.64%)

IDXX Idexx Laboratories
$529.59 /

-3.96 (-0.74%)

HSKA Heska
$207.78 /

-0.35 (-0.17%)

ELAN Elanco
$32.14 /

+0.57 (+1.81%)

  • 01
    Dec
ZTS Zoetis
$158.94 /

-0.1 (-0.06%)

ELAN Elanco
$32.14 /

+0.57 (+1.81%)

PAHC Phibro Animal Health
$21.80 /

-0.04 (-0.18%)

ELAN Elanco
$32.14 /

+0.57 (+1.81%)

IDXX Idexx Laboratories
$529.59 /

-3.96 (-0.74%)

ELAN Elanco
$32.14 /

+0.57 (+1.81%)

Earnings
Phibro Animal Health sees Q3 adjusted EPS 30c-33c, consensus 33c » 16:46
02/03/21
02/03
16:46
02/03/21
16:46
PAHC

Phibro Animal Health

$22.09 /

+0.96 (+4.54%)

Sees Q3 revenue…

Sees Q3 revenue $205M-$208M, consensus $212.68M.

ShowHide Related Items >><<
PAHC Phibro Animal Health
$22.09 /

+0.96 (+4.54%)

PAHC Phibro Animal Health
$22.09 /

+0.96 (+4.54%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold on valuation at Gabelli
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold from Buy at Gabelli
PAHC Phibro Animal Health
$22.09 /

+0.96 (+4.54%)

PAHC Phibro Animal Health
$22.09 /

+0.96 (+4.54%)

Earnings
Phibro Animal Health reports Q2 adjusted EPS 34c, consensus 27c » 16:46
02/03/21
02/03
16:46
02/03/21
16:46
PAHC

Phibro Animal Health

$22.09 /

+0.96 (+4.54%)

Reports Q2 revenue $206M,…

Reports Q2 revenue $206M, consensus $206.36M. "Our financial results for the quarter ended December 31, 2020 were strong. Although sales declined, profitability improved in comparison to the same quarter last year," said Jack Bendheim, Phibro's Chairman, President and Chief Executive Officer. Jack continued, "We are encouraged by signs the industry is stabilizing, despite the continued pandemic, and we continue to invest in the future in both our production and pet business. We recently announced an upgrade of our Omaha mineral nutrition plant and development continues on two early-stage opportunities in our pet business. We are cautiously optimistic about the near term and, as detailed in our updated guidance, are projecting solid third quarter financial results."

ShowHide Related Items >><<
PAHC Phibro Animal Health
$22.09 /

+0.96 (+4.54%)

PAHC Phibro Animal Health
$22.09 /

+0.96 (+4.54%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold on valuation at Gabelli
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold from Buy at Gabelli
PAHC Phibro Animal Health
$22.09 /

+0.96 (+4.54%)

PAHC Phibro Animal Health
$22.09 /

+0.96 (+4.54%)

Earnings
Phibro Animal Health sees Q2 adjusted EPS 28c, consensus 33c » 16:41
11/04/20
11/04
16:41
11/04/20
16:41
PAHC

Phibro Animal Health

$17.40 /

+0.56 (+3.33%)

Sees Q2 revenue roughly…

Sees Q2 revenue roughly $205M, consensus $213.7M.

ShowHide Related Items >><<
PAHC Phibro Animal Health
$17.40 /

+0.56 (+3.33%)

PAHC Phibro Animal Health
$17.40 /

+0.56 (+3.33%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold on valuation at Gabelli
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold from Buy at Gabelli
PAHC Phibro Animal Health
$17.40 /

+0.56 (+3.33%)

PAHC Phibro Animal Health
$17.40 /

+0.56 (+3.33%)

Earnings
Phibro Animal Health reports Q1 adjusted EPS 27c, consensus 23c » 16:41
11/04/20
11/04
16:41
11/04/20
16:41
PAHC

Phibro Animal Health

$17.40 /

+0.56 (+3.33%)

Reports Q1 revenue $195M,…

Reports Q1 revenue $195M, consensus $189.07M. "Our financial results for the September 2020 quarter reflected the continuing recovery of the industry sectors we serve," said Jack Bendheim, Phibro's Chairman, President and Chief Executive Officer. "We saw improved sales and profitability, compared with the same quarter last year, and in particular, sequential improvement over the June 2020 quarterly results. As more fully described in our earnings guidance, we are forecasting additional sequential improvement for our December 2020 quarter, as the industry continues to adjust and move toward more typical operating levels. At the same time, we remain cautious in the face of ongoing uncertainties resulting from the pandemic."

ShowHide Related Items >><<
PAHC Phibro Animal Health
$17.40 /

+0.56 (+3.33%)

PAHC Phibro Animal Health
$17.40 /

+0.56 (+3.33%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold on valuation at Gabelli
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold from Buy at Gabelli
PAHC Phibro Animal Health
$17.40 /

+0.56 (+3.33%)

PAHC Phibro Animal Health
$17.40 /

+0.56 (+3.33%)

Conference/Events
Phibro Animal Health management to meet virtually with Gabelli » 04:55
09/30/20
09/30
04:55
09/30/20
04:55
PAHC

Phibro Animal Health

$17.32 /

-0.47 (-2.64%)

Virtual Meeting to be…

Virtual Meeting to be held on September 30 hosted by Gabelli.

ShowHide Related Items >><<
PAHC Phibro Animal Health
$17.32 /

-0.47 (-2.64%)

PAHC Phibro Animal Health
$17.32 /

-0.47 (-2.64%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold on valuation at Gabelli
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold from Buy at Gabelli
PAHC Phibro Animal Health
$17.32 /

-0.47 (-2.64%)

PAHC Phibro Animal Health
$17.32 /

-0.47 (-2.64%)

Conference/Events
Phibro Animal Health management to meet virtually with Gabelli » 13:31
09/23/20
09/23
13:31
09/23/20
13:31
PAHC

Phibro Animal Health

$17.78 /

+0.23 (+1.31%)

Virtual Meeting to be…

Virtual Meeting to be held on September 30 hosted by Gabelli.

ShowHide Related Items >><<
PAHC Phibro Animal Health
$17.78 /

+0.23 (+1.31%)

PAHC Phibro Animal Health
$17.78 /

+0.23 (+1.31%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold on valuation at Gabelli
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold from Buy at Gabelli
PAHC Phibro Animal Health
$17.78 /

+0.23 (+1.31%)

PAHC Phibro Animal Health
$17.78 /

+0.23 (+1.31%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.